Hem › Neuroblastom › Kalifornien › Oakland
Kliniska studier för Neuroblastom i Oakland, CA
5 studier för Neuroblastom söker deltagare vid platser i och runt Oakland (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RekryterarFas 3
- UCSF Benioff Children's Hospital Oakland, Oakland
- Kaiser Permanente-Oakland, Oakland
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
RekryterarFas 2
- UCSF Benioff Children's Hospital Oakland, Oakland
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RekryterarFas 1/2
- UCSF Benioff Children's Hospital Oakland, Oakland
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RekryterarFas 3
- Kaiser Permanente-Oakland, Oakland
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
RekryterarFas 2
- UCSF Benioff Children's Hospital Oakland, Oakland
Neuroblastom-studier i andra städer
- Boston, MA13 studier
- Washington, DC11 studier
- New York City, NY10 studier
- Memphis, TN9 studier
- Philadelphia, PA9 studier
- Dallas, TX9 studier
- St. Louis, MO9 studier
- Aurora, CO8 studier
- Hartford, CT8 studier
- Minneapolis, MN8 studier
- Birmingham, AL8 studier
- Atlanta, GA7 studier
Andra studier i Oakland
- Akut myeloid leukemi7 studier
- Bröstcancer7 studier
- Sickelcellssjukdom7 studier
- Icke-småcellig lungcancer6 studier
- Lungcancer6 studier
- Prostatacancer6 studier
- Burkitts lymfom6 studier
- Cancer (alla typer)5 studier
- Osteosarkom4 studier
- Esophageal adenocarcinom4 studier
- Melanom4 studier
- Alzheimers sjukdom4 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.